KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,623,999 | -38.0% | 1,932,456 | -28.1% | 5.58% | +31.1% |
| Q2 2023 | $28,425,476 | +764.0% | 2,686,718 | +2402.4% | 4.26% | +172.1% |
| Q3 2020 | $3,290,000 | -70.5% | 107,367 | -84.3% | 1.56% | -67.3% |
| Q2 2020 | $11,166,000 | -22.6% | 685,000 | -52.8% | 4.79% | -28.9% |
| Q1 2020 | $14,428,000 | +1.3% | 1,450,000 | +40.0% | 6.74% | +7.8% |
| Q4 2019 | $14,245,000 | +5.7% | 1,036,000 | +16.6% | 6.26% | -16.3% |
| Q3 2019 | $13,473,000 | -21.2% | 888,152 | +2.3% | 7.47% | -13.2% |
| Q2 2019 | $17,087,000 | +495.8% | 867,810 | +401.9% | 8.62% | +586.5% |
| Q1 2019 | $2,868,000 | -35.5% | 172,894 | -45.4% | 1.26% | -45.3% |
| Q4 2018 | $4,445,000 | +0.1% | 316,581 | +24.8% | 2.30% | -7.3% |
| Q3 2018 | $4,439,000 | -15.3% | 253,631 | -11.9% | 2.48% | -35.6% |
| Q2 2018 | $5,240,000 | – | 287,887 | – | 3.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |